GT200200258A - Combinacion farmaceutica - Google Patents
Combinacion farmaceuticaInfo
- Publication number
- GT200200258A GT200200258A GT200200258A GT200200258A GT200200258A GT 200200258 A GT200200258 A GT 200200258A GT 200200258 A GT200200258 A GT 200200258A GT 200200258 A GT200200258 A GT 200200258A GT 200200258 A GT200200258 A GT 200200258A
- Authority
- GT
- Guatemala
- Prior art keywords
- pharmaceutical combination
- respiratory
- adenosine
- asthma
- record
- Prior art date
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 2
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
- 229960005305 adenosine Drugs 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 230000005801 respiratory difficulty Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA COMBINACION INHALADA DE UN AGONISTA DEL RECEPTOR DE ADENOSINA A2A DE FORMULA GENERAL I EN DONDE R1,R2,R3,R4,R5,R15,X,Y, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. SON DE UTILIDAD EN EL TRATAMIENTO DE ENFERMEDADES OBSTRUCTIVAS DE LAS VIAS RESPIRATORIAS TALES COMO ASMA, SINDROME DE DIFICULTAD RESPIRATORIA, BRONQUITIS CRONICA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129270.5A GB0129270D0 (en) | 2001-12-06 | 2001-12-06 | Pharmaceutical combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200200258A true GT200200258A (es) | 2003-08-22 |
Family
ID=9927164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200200258A GT200200258A (es) | 2001-12-06 | 2002-12-05 | Combinacion farmaceutica |
Country Status (37)
| Country | Link |
|---|---|
| EP (1) | EP1455799B1 (es) |
| JP (1) | JP2005513041A (es) |
| KR (1) | KR100685557B1 (es) |
| CN (1) | CN1856314A (es) |
| AP (2) | AP2004003082A0 (es) |
| AR (1) | AR037634A1 (es) |
| AT (1) | ATE293982T1 (es) |
| AU (1) | AU2002351066B2 (es) |
| BR (1) | BR0214998A (es) |
| CA (1) | CA2469085A1 (es) |
| CO (1) | CO5580752A2 (es) |
| DE (1) | DE60203934T2 (es) |
| DK (1) | DK1455799T3 (es) |
| EA (1) | EA200400639A1 (es) |
| EC (1) | ECSP045132A (es) |
| ES (1) | ES2239728T3 (es) |
| GB (1) | GB0129270D0 (es) |
| GT (1) | GT200200258A (es) |
| HN (1) | HN2002000348A (es) |
| HR (1) | HRP20040517A2 (es) |
| HU (1) | HUP0402540A3 (es) |
| IS (1) | IS7280A (es) |
| MA (1) | MA27150A1 (es) |
| MX (1) | MXPA04005506A (es) |
| NO (1) | NO20042839L (es) |
| NZ (1) | NZ533054A (es) |
| OA (1) | OA12738A (es) |
| PA (1) | PA8560701A1 (es) |
| PE (1) | PE20030834A1 (es) |
| PL (1) | PL370739A1 (es) |
| PT (1) | PT1455799E (es) |
| SV (1) | SV2004001426A (es) |
| TN (1) | TNSN04101A1 (es) |
| TW (1) | TWI256388B (es) |
| UY (1) | UY27566A1 (es) |
| WO (1) | WO2003047598A1 (es) |
| ZA (1) | ZA200403966B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100785969B1 (ko) * | 2004-05-12 | 2007-12-14 | 동아제약주식회사 | Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성폐질환 예방 또는 치료제 |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US10149823B2 (en) | 2013-04-30 | 2018-12-11 | Otitopic Inc. | Dry powder formulations and methods of use |
| CN115919780A (zh) | 2017-09-22 | 2023-04-07 | 维克图拉公司 | 含有硬脂酸镁的干粉组合物 |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| JPWO2022050230A1 (es) * | 2020-09-03 | 2022-03-10 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003960D0 (en) * | 2000-02-18 | 2000-04-12 | Pfizer Ltd | Purine derivatives |
| TWI227240B (en) * | 2000-06-06 | 2005-02-01 | Pfizer | 2-aminocarbonyl-9H-purine derivatives |
-
2001
- 2001-12-06 GB GBGB0129270.5A patent/GB0129270D0/en not_active Ceased
-
2002
- 2002-11-28 AU AU2002351066A patent/AU2002351066B2/en not_active Ceased
- 2002-11-28 AT AT02785778T patent/ATE293982T1/de not_active IP Right Cessation
- 2002-11-28 BR BR0214998-2A patent/BR0214998A/pt not_active IP Right Cessation
- 2002-11-28 WO PCT/IB2002/005057 patent/WO2003047598A1/en not_active Ceased
- 2002-11-28 JP JP2003548853A patent/JP2005513041A/ja active Pending
- 2002-11-28 NZ NZ533054A patent/NZ533054A/en unknown
- 2002-11-28 HR HR20040517A patent/HRP20040517A2/hr not_active Application Discontinuation
- 2002-11-28 EP EP02785778A patent/EP1455799B1/en not_active Expired - Lifetime
- 2002-11-28 DE DE60203934T patent/DE60203934T2/de not_active Expired - Fee Related
- 2002-11-28 EA EA200400639A patent/EA200400639A1/ru unknown
- 2002-11-28 HU HU0402540A patent/HUP0402540A3/hu unknown
- 2002-11-28 OA OA1200400164A patent/OA12738A/en unknown
- 2002-11-28 PL PL02370739A patent/PL370739A1/xx not_active Application Discontinuation
- 2002-11-28 CN CNA028244168A patent/CN1856314A/zh active Pending
- 2002-11-28 DK DK02785778T patent/DK1455799T3/da active
- 2002-11-28 MX MXPA04005506A patent/MXPA04005506A/es active IP Right Grant
- 2002-11-28 CA CA002469085A patent/CA2469085A1/en not_active Abandoned
- 2002-11-28 AP APAP/P/2004/003082A patent/AP2004003082A0/en unknown
- 2002-11-28 KR KR1020047008609A patent/KR100685557B1/ko not_active Expired - Fee Related
- 2002-11-28 ES ES02785778T patent/ES2239728T3/es not_active Expired - Lifetime
- 2002-11-28 PT PT02785778T patent/PT1455799E/pt unknown
- 2002-11-28 AP APAP/P/2004/003053A patent/AP2004003053A0/en unknown
- 2002-11-29 TW TW091134818A patent/TWI256388B/zh not_active IP Right Cessation
- 2002-12-03 HN HN2002000348A patent/HN2002000348A/es unknown
- 2002-12-03 PE PE2002001164A patent/PE20030834A1/es not_active Application Discontinuation
- 2002-12-04 AR ARP020104685A patent/AR037634A1/es unknown
- 2002-12-05 UY UY27566A patent/UY27566A1/es not_active Application Discontinuation
- 2002-12-05 SV SV2002001426A patent/SV2004001426A/es not_active Application Discontinuation
- 2002-12-05 GT GT200200258A patent/GT200200258A/es unknown
- 2002-12-06 PA PA20028560701A patent/PA8560701A1/es unknown
-
2004
- 2004-05-21 ZA ZA200403966A patent/ZA200403966B/xx unknown
- 2004-05-21 IS IS7280A patent/IS7280A/is unknown
- 2004-06-02 MA MA27710A patent/MA27150A1/fr unknown
- 2004-06-03 CO CO04052108A patent/CO5580752A2/es not_active Application Discontinuation
- 2004-06-04 EC EC2004005132A patent/ECSP045132A/es unknown
- 2004-06-04 TN TNP2004000101A patent/TNSN04101A1/fr unknown
- 2004-07-05 NO NO20042839A patent/NO20042839L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200601160A1 (ru) | 2,6-бисгетероарил-4-аминопиримидины в качестве антагонистов аденозиновых рецепторов | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| CY1115199T1 (el) | Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση | |
| DK1628685T3 (da) | Antivirale phosphonatanaloge | |
| GT200200012A (es) | Derivados de eteres utiles como agentes inhibidores de las isozimas pde4 | |
| BRPI0509369A (pt) | azaindóis úteis como inibidores de jak e outras proteìna cinases | |
| SG145693A1 (en) | Amino acid prodrugs | |
| CY1111169T1 (el) | Βενζοϊμιδαζολ-2-υλ πυριμιδινες και πυραζινες ως τροποποιητες του υποδοχεα ισταμινης h4 | |
| DK1951729T3 (da) | Oxygenbundne pyrimidinderivater | |
| ATE383872T1 (de) | Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzung | |
| IL204732A (en) | @@@@@ - Diplooro - @@ - Deoxy @ tetrahydro uridines, preparations containing them and their use in making @ drugs | |
| ECSP055640A (es) | Composiciones de pirazol útiles como inhibidores de gsk-3 | |
| TW200716596A (en) | Substituted amide derivatives and methods of use | |
| ATE426414T1 (de) | Vitamin-mitomycin-konjugate | |
| CR10682A (es) | Compuestos de tiazol pirazolopirimidina | |
| WO2004106335A8 (en) | Harmine derivatives, intermediates used in their preparation, preparation processes and use thereof | |
| ECSP077331A (es) | Nuevos betamiméticos para el tratamiento de enfermedades de vías respiratorias | |
| CY1108324T1 (el) | Νεοι τεταρτοταγοποιημενοι εστερες κουινουκλιδινης | |
| WO2004096233A3 (en) | Nucleoside phosphonate conjugates | |
| WO2005111002A3 (de) | Substituierte cycloalkylderivate zur behandlung von atemswegerkrankungen | |
| GT200300033A (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
| CL2007003754A1 (es) | Compuestos derivados de aril(heteroaril)alquil-amina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como bronquitis, enfisema pulmonar y epoc. | |
| GT200200258A (es) | Combinacion farmaceutica | |
| TW200740814A (en) | Compounds | |
| ATE538124T1 (de) | Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit |